http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200082724-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd7648b9a1f9b5a4f8fddb982ec140aa |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-217 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-191 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 |
| filingDate | 2018-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bd27abba8475068c429f1d7a06ffda4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad2515b69cfa25bd315565e64819fb1c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e606898dc2d33b4c4402e79887dd256 |
| publicationDate | 2020-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20200082724-A |
| titleOfInvention | Pharmaceutical composition for prevention and treatment of cancer including Glycolipid from Lipoteichoic Acid |
| abstract | The present invention relates to an anticancer composition comprising glycolipids separated from lipoicoteic acid, which is a cell wall component of Gram-positive bacteria, and TNF-alpha and IFN-gamma as active ingredients, and the anticancer composition of the present invention is lipoteicoic acid Since the derived glycolipids, TNF-α and IFN-γ act on target cells, cancer cells specifically activate the signaling system associated with self-killing and have fewer side effects than conventional anticancer drugs, and for the active site of lipoteicoic acid By synthesizing the derivative, it not only increases the efficiency of the anti-cancer effect, but also has an excellent anti-cancer effect because cancer cells die within 24 hours. |
| priorityDate | 2018-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 310.